Kala Pharmaceuticals Inc (KALA) Insider Trading
- $110,097,301.61
- $1,637,831.97
- Jan. 4, 2024
- Orbimed Advisors Llc
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Jan. 4, 2024 | Insider | 1,227 | $6.74 | Sell | $8,269.98 | |
| Jan. 4, 2024 | CEO | 4,539 | $6.73 | Sell | $30,547.47 | |
| Jan. 4, 2023 | Insider | 60 | $28.55 | Sell | $1,713.00 | |
| Jan. 4, 2023 | CEO | 198 | $28.54 | Sell | $5,650.92 | |
| Oct. 26, 2022 | CEO | 561 | $6.52 | Sell | $3,657.72 | |
| Oct. 26, 2022 | Insider | 194 | $6.52 | Sell | $1,264.88 | |
| June 27, 2022 | Insider | 2,613 | $0.37 | Sell | $966.81 | |
| June 27, 2022 | CEO | 7,975 | $0.37 | Sell | $2,950.75 | |
| May 25, 2022 | Major Shareholder | 1,434,509 | $0.42 | Sell | $602,493.78 | |
| May 23, 2022 | Major Shareholder | 1,250,000 | $0.65 | Sell | $812,500.00 | |
| Jan. 4, 2022 | CEO | 9,518 | $1.30 | Sell | $12,373.40 | |
| Jan. 4, 2022 | CFO | 2,850 | $1.30 | Sell | $3,705.00 | |
| Jan. 4, 2022 | Insider | 3,504 | $1.30 | Sell | $4,555.20 | |
| Oct. 26, 2021 | CEO | 27,598 | $1.80 | Sell | $49,676.40 | |
| Oct. 26, 2021 | Insider | 9,449 | $1.80 | Sell | $17,008.20 | |
| Oct. 26, 2021 | COO | 12,544 | $1.80 | Sell | $22,579.20 | |
| June 28, 2021 | CEO | 7,586 | $5.77 | Sell | $43,771.22 | |
| June 28, 2021 | Insider | 2,452 | $5.77 | Sell | $14,148.04 | |
| Oct. 22, 2020 | COO | 40 | $7.60 | Buy | $304.00 | |
| June 5, 2020 | COO | 2 | $13.39 | Buy | $26.78 | |
| March 16, 2020 | COO | 10,000 | $5.75 | Buy | $57,500.00 | |
| March 13, 2020 | Director | 6,337,135 | $7.89 | Buy | $49,999,995.15 | |
| May 30, 2019 | Director | 5,000 | $5.42 | Buy | $27,100.00 | |
| Oct. 5, 2018 | Director | 606,060 | $8.25 | Buy | $4,999,995.00 | |
| Oct. 3, 2018 | Director | 2,424,242 | $8.25 | Buy | $19,999,996.50 | |
| Feb. 8, 2018 | Major Shareholder | 25,000 | $12.93 | Buy | $323,250.00 | |
| Feb. 1, 2018 | Major Shareholder | 362,240 | $15.00 | Buy | $5,433,600.00 | |
| Jan. 29, 2018 | Major Shareholder | 72,760 | $14.97 | Buy | $1,089,217.20 | |
| Jan. 26, 2018 | Major Shareholder | 22,760 | $14.93 | Buy | $339,806.80 | |
| Jan. 24, 2018 | Major Shareholder | 64,637 | $14.91 | Buy | $963,737.67 | |
| Jan. 22, 2018 | Major Shareholder | 75,000 | $14.98 | Buy | $1,123,500.00 | |
| Jan. 19, 2018 | Major Shareholder | 74,931 | $14.95 | Buy | $1,120,218.45 | |
| Jan. 12, 2018 | Major Shareholder | 240,484 | $13.28 | Buy | $3,193,627.52 | |
| Jan. 10, 2018 | Major Shareholder | 170,338 | $12.83 | Buy | $2,185,436.54 | |
| July 25, 2017 | Insider | 319,333 | $15.00 | Buy | $4,789,995.00 | |
| July 25, 2017 | Major Shareholder | 215,000 | $15.00 | Buy | $3,225,000.00 | |
| July 25, 2017 | Director | 533,333 | $15.00 | Buy | $7,999,995.00 | |
| July 20, 2017 | Major Shareholder | 215,000 | $15.00 | Buy | $3,225,000.00 |
Insiders are both buying and selling Kala Pharmaceuticals Inc stock.
The insider traders at Kala Pharmaceuticals Inc are: Orbimed Advisors Llc, Mark T Iwicki, Eric Trachtenberg, Todd Bazemore, Ra Capital Management, L.P., Hongming Chen, Rajeev M Shah, Romulus K Brazzell, Mark T. Iwicki, Gregory Grunberg, Howard B Rosen, Longitude Capital Partners Ii,, Associates L.L.C. Cdk, Mary Reumuth, and Ra Capital Healthcare Fund Lp
The most active insider trader at Kala Pharmaceuticals Inc is Orbimed Advisors Llc with 10 trades.
Ra Capital Management, L.P. has sold the most Kala Pharmaceuticals Inc stock with a total value of $2,017,487.56.
Rajeev M Shah has bought the most Kala Pharmaceuticals Inc stock with a total value of $107,999,985.30.
The most recent insider trade for Kala Pharmaceuticals Inc was on Jan. 4, 2024.
The single biggest insider buy for Kala Pharmaceuticals Inc was from Rajeev M Shah with a total value of $49,999,995.15 on March 13, 2020.
The single biggest insider sell for Kala Pharmaceuticals Inc was from Ra Capital Management, L.P. with a total value of $812,500.00 on May 23, 2022.